论文信息 - Doravirine dose Selection and 96-Week Safety and Efficacy versus Efavirenz in Antiretroviral Therapy-Naive Adults with HIV-1 Infection in a Phase IIb Trial - 字舞流文

Doravirine dose Selection and 96-Week Safety and Efficacy versus Efavirenz in Antiretroviral Therapy-Naive Adults with HIV-1 Infection in a Phase IIb Trial

J. Gatell | H. Teppler | F. Raffi | A. Rodgers | Charlotte M. Harvey | C. Hoffmann | J. Morales-Ramirez | S. Rugină | Don E. Smith | K. Arastéh | J. Portilla | M. Thompson | A. Plettenberg | Sushma Kumar | C. Frobose | C. Hwang | D. Hagins | O. Osiyemi | R. Dretler | Xia Xu | H. Wan | S. Rugina